Overall Survival in Older Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) with > 30% Bone Marrow Blasts Treated with Azacitidine By Cytogenetic Risk Status: Results of the AZA-AML-001 Study
Autor(es) y otros:
Fecha de publicación:
2014